MedPath
NMPA Approval

Oseltamivir Phosphate for Suspension

国药准字H20253138

January 14, 2025

Drug Information

磷酸奥司他韦干混悬剂

口服混悬剂

0.36g(按C₁₆H₂₈N₂O₄计)

化学药品

January 14, 2025

Company Information

Applicant Company

福建省福州市闽侯县上街镇科技东路12、16、18号华建大厦5号楼706-1

Manufacturing Company

江苏省海门经济技术开发区定海路688号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸奥司他韦干混悬剂 - NMPA 批准文号 | MedPath